In: News
The TRANS-INT project brings important advances in the use of nanotechnology for the development of new oral therapies, with relevance for the treatment of diabetes, obesity and other pathologies
April 24, 2017The European consortium “TRANS-INT” finishes the project “New oral nanomedicines: transporting therapeutic macromolecules across the intestinal barrier”
Read More
María José Alonso, elected Member of the College of Fellows of the American Institute for Medical and Biological Engineering (AIMBE)
March 21, 2017This is a new recognition of the outstanding scientific career of Professor Alonso by American institutions, after her election to the US National Academy of Medicine in 2016. The College of Fellows of the American Institute for Medical and Biological Engineering (AIMBE) consists of over 1,500 individuals who are the outstanding leaders, engineers, entrepreneurs, and innovators in medical and biological engineering. They represent the top 2% of the medical and biological engineering community
Read More
María José Alonso leads the ranking of Spanish researchers in Pharmacy and Pharmacology
January 11, 2017Professor Alonso has reached h-index 65 according to the last update of this ranking, an indicator of the researchers’ influence
Read More
María José Alonso, elected International Member of the US National Academy of Medicine
October 17, 2016Election to the Academy is considered one of the highest honors in the fields of health and medicine and recognizes individuals who have demonstrated outstanding professional achievement and commitment to service
Read More
Congratulations Matilde and Sofía!
September 30, 2016Our colleagues in the Lab Matilde Durán and Sofía Mendes are the winners of the Yuzz Mujer 2016 Award.
Read More
María José Alonso, elected Secretary of the Controlled Release Society
July 18, 2016María José Alonso, Professor of Biopharmaceutics and Pharmaceutical Technology at the University of Santiago de Compostela (USC), has been elected Secretary of the Controlled Release Society, Inc. (CRS, Inc), the worldwide leading organization whose goal is to promote and foster delivery sciences and technologies.
Read More
Controlled Release Society (CRS) Annual Meeting in Seattle
July 18, 2016I encourage you to join us to the Controlled Release Society (CRS) annual Meeting in Seattle, July 17-20. New this year -Industry Roundtables- discuss the latest hot topics affecting the industry with the experts. The 2016 program has the largest participation from industry to-date with companies like Boehring, Ingelheim, Catalent, Capsugel, Merck and Pfizer.
Read More